Showing results (51-60 of 476) with videos related to
Sort By:
Pageof 48
Cancer Research|February 1, 1978
Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosoureaP S Schein, J M Bull, D Doukas, et al.Journal of Biological Response Modifiers|August 1, 1984
Minimal activity of recombinant clone a interferon in metastatic colon cancerJ R Neefe, R Silgals, M Ayoob, et al.Annals of Internal Medicine|June 1, 1985
Carcinoid carcinomatous meningitisR A Nagourney, R Hedaya, M Linnoila, et al.Cancer Research|February 1, 1987
6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicityP S Schein, D Green, S W Dean, et al.Biochemical Pharmacology|May 1, 1982
Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sitesD Green, K D Tew, T Hisamatsu, et al.Bulletin Du Cancer|January 1, 1979
Studies on mechanisms of 5-fluorouracil resistance in murine and human tumorsB Ardalan, J S Macdonald, D Cooney, et al.Cancer Treatment Reports|June 1, 1976
Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agentP S Schein, L Panasci, P V Woolley, et al.Anti-Cancer Drug Design|November 1, 1990
Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicityA H Talebian, D Bensely, P S Schein, et al.Molecular and Cellular Endocrinology|June 1, 1981
Autoantibodies to insulin receptorsE Van Obberghen, C R KahnThe Journal of Clinical Endocrinology and Metabolism|July 1, 1989
Insulin receptor messenger ribonucleic acid sequence alterations detected by ribonuclease cleavage in patients with syndromes of insulin resistanceB J Goldstein, C R KahnPageof 48